Sarcopenia and the Brain

John E. Morley

doi:10.1590/0004-282X-ANP-2021-e005

Arquivos de Neuro-Psiquiatria, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2021; 79(05): 373-375
DOI: 10.1590/0004-282X-ANP-2021-e005

Editorial

Sarcopenia and the Brain

Sarcopenia e Cérebro

Authors

John E. Morley

¹Saint Louis University, School of Medicine, Division of Geriatric Medicine, St. Louis MO, United States of America.

Abstract

Volltext

Referenzen

References
1 Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001 Apr;137(4):231-43. https://doi.org/10.1067/mlc.2001.113504
2 Cruz-Jentoff AJ, Baeyens JP, Bauer J, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. https://doi.org/10.1093/ageing/afq034
3 Cruz-Jentoff AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan;48(1):16-31. https://doi.org/10.1093/ageing/afy169
4 Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, diagnosis and management. J Nutr Health Aging. 2018 Dec;22(10):1148-61. https://doi.org/10.1007/s12603-018-1139-9
5 Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, et al. Sarcopenia: a time for action. An SCWD position paper. J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):956-61. https://doi.org/10.1002/jcsm.12483
6 Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):28-36. https://doi.org/10.1002/jcsm.12048
7 Ha Y-C, Won C, Kim M, Chun K-J, Yoo J-I. SARC-F as a useful tool for screening sarcopenia in elderly patients with hip fractures. J Nutr Health Aging. 2020;24(1):78-82. https://doi.org/10.1007/s12603-019-1307-6
8 Lu J-L, Ding L-Y, Xu Q, Zhu S-Q, Xu X-Y, Hua H-X, Chen L, Xu H. Screening accuracy of SARC-F for sarcopenia in the elderly: a diagnostic meta-analysis. J Nutr Health Aging. 2021 Feb;25(2):172-82. https://doi.org/10.1007/s12603-020-1471-8
9 Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):512-4. https://doi.org/10.1002/jcsm.12147
10 Tsutsumimoto K, Doi T, Nakakubo S, Kim M, Kurita S, Ishii H, Shimada H. Cognitive frailty as a risk factor for incident disability during late life; A 24-month follow-up longitudinal study. J Nutr Health Aging. 2020;24(5):494-9. https://doi.org/10.1007/s12603-020-1365-9
11 Ge M, Zhang Y, Zhao W, Yu J, Hou L, Xia X, et al. Prevalence and its associated factors of physical frailty and cognitive impairment: Findings from the West China Health and Aging Trend Study (WCHAT). J Nutr Health Aging. 2020;24(5):525-33. https://doi.org/10.1007/s12603-020-1363-y
12 Wearing J, Konings P, de Bie RA, Stokes M, de Bruin ED. Prevalence of probable sarcopenia in community-dwelling older Swiss people – a cross-sectional study. BMC Geriatr. 2020 Aug 26;20(1):307. https://doi.org/10.1186/s12877-020-01718-1
13 Basile G, Sardella A. From cognitive to motor impairment and from sarcopenia to cognitive impairment: A bidirectional pathway towards frailty and disability. Aging Clin Exp Res. 2021 Feb;33(2):469-78. https://doi.org/10.1007/s40520-020-01550-y
14 Cipolli GC, Aprahamian I, Borim FSA, Falcao DVS, Cachioni M, Melo RC, et al. Probable sarcopenia is associated with cognitive impairment among community dwelling older adults: Results from the FIBRA study. Arq Neuro-Psyquiatr. 2021 May;79(5):XX-XX. https://doi.org/10.1590/0004-282X-ANP-2020-0186
15 Sanford AM, Morley JE, Berg-Weger M, Lundy J, Little MO, Leonard K, Malmstrom TK. High prevalence of geriatric syndromes in older adults. PLoS One. 2020 Jun;15(6):e0233857. https://doi.org/10.1371/journal.pone.0233857
16 Morley JE. Bidirectional communication between brain and muscle. J Nutr Health Aging 2018 Dec;22:1144-5. https://doi.org/10.1007/s12603-018-1141-2
17 Scisciola L, Fontanella RA, Rusina Cataldo V, Paolisso G, Barbieri M. Sarcopenia and cognitive function: Role of myokines in muscle brain cross-talk. Life (Basel). 2021 Feb;11(2):173. https://doi.org/10.3390/life11020173
18 Bray NW, Pieruccini-Faria F, Bartha R, Doherty TJ, Nagamatsu LS, Montero-Odasso M. The effect of physical exercise on functional brain network connectivity in older adults with and without cognitive impairment. A systematic review. Mech Ageing Dev. 2021 Apr;196:111493. https://doi.org/10.1016/j.mad.2021.111493
19 Lourenco MV, Frozza RL, de Freitas GB, Zhang H, Kincheski GC, Ribeiro FC, et al. Exercise-linked FNDC5/Irisin rescues synaptic plasticity and memory defects in Alzheimer's models. Nat Med. 2019 Jan;25(1):165-75. https://doi.org/10.1038/s41591-018-0275-4
20 de Freitas GB, Lourenco MV, De Felice FG. Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease. J Neurochem. 2020 Dec;155(6):602-11. https://doi.org/10.1111/jnc.15039
21 Lourenco MV, Ribeiro FC, Sudo FK, Drummond C, Assunção N, Vanderborght B, Tovar-Moll F, Mattos P, De Felice FG, Ferreira ST. Cerebrospinal fluid irisin correlates with amyloid-β, BDNF, and cognition in Alzheimer's disease. Alzheimers Dement. 2020 Jun 21;12(1):e12034. https://doi.org/10.1002/dad2.12034
22 Kim OY, Song J. The role of irisin in Alzheimer's disease. J Clin Med. 2018 Nov;7(11):407. https://doi.org/10.3390/jcm7110407
23 Delezie J, Handschin C. Endocrine crosstalk between skeletal muscle and the brain. Front Neurol. 2018 Aug;9:698. https://doi.org/10.3389/fneur.2018.00698
24 Lee HJ, Lee JO, Lee YW, Kim SA, Seo IH, Han JA, et al. LIF, a novel myokine, protects against amyloid-beta-induced neurotoxicity via Akt-Mediated autophagy signaling in hippocampal cells. Int J Neuropsychopharmacol. 2019 Jun;22(6):402-14. https://doi.org/10.1093/ijnp/pyz016
25 Seok Hyung WW, Lee SG, Kim KT, Kim HS. Oncostatin M, a muscle-secreted myokine, recovers high-glucose0induced impairment of Akt phosphorylation by Fos induction in hippocampal neuron cells. Neuroreport. 2019 Aug;30(11):765-70. https://doi.org/10.1097/WNR.2021e0052021e0051271
26 Carson RG. Get a grip: Individual variations in grip strength are a marker of brain health. Neurobiol Aging. 2018 Nov;71:189-222. https://doi.org/10.1016/j.neurobiolaging.2018.07.023
27 Del Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, et al. MPI:DSA study group. Relationship of regional brain β-amyloid to gait speed. Neurology. 2016 Jan;86(1):36-43. https://doi.org/10.1212/WNL.2021e0052021e0052235
28 Manini TM, Hong SL, Clark BC. Aging and muscle: a neuron's perspective. Curr Opin Clin Nutr Metab Care. 2013 Jan;16(1):21-6. https://doi.org/10.1097/MCO.0b013e32835b5880
29 Cipolli GC, Yassuda MS, Aprahamian I. Sarcopenia is associated with cognitive impairment in older adults: a systematic review and meta-analysis. J Nutr Health Aging. 2019;23(6):525-31. https://doi.org/10.1007/s12603-019-1188-8
30 Moon JH, Moon JH, Kim KM, Choi SH, Lim S, Park KS, et al. Sarcopenia as a predictor of future cognitive impairment in older adults. J Nutr Health Aging. 2016;20(5):496-502. https://doi.org/10.1007/s12603-015-0613-x
31 Lundy J, Hayden D, Pyland S, Berg-Weger M, Malmstrom TK, Morley JE. An age-friendly health system. J Am Geriatr Soc. 2018 Jan;66(1):22-4. https://doi.org/10.1111/jgs.15076